MAP1LC3B and neoplasm: As depicted in Figure 5, the staining revealed overall for ASA404 treated BON-tumors that some treatment affected tumor regions (Figure 5A), which stained higher for LC3B (Figure 5C) compared to the NaCl-treated controls (Figure 5E), and also in NCI-H295R tumors (Figure 5B,D,F), but did not lead to obviously detectable LC3BII punctae under the chosen analytical setting.